# Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus

> **NCT00304603** · — · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 1145 (actual)

## Conditions studied

- Obesity
- Diabetes Mellitus Type 2

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT00304603
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2005-04
- **Final completion:** 2005-04
- **Target enrollment:** 1145 (ACTUAL)
- **Last updated:** 2012-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304603, "Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00304603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*